drugs MODERATE Updated 2024-02-28

MCKESSON CORPORATION recalls CABTREO (clindamycin phosphate, adapalene and benzoyl peroxi

See all recalls from MCKESSON CORPORATION →

Recalled Product

CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, Not for Oral, Ophthalmic or Intravaginal Use, Rx Only, Net Wt. 50g, Distributed by Bausch Health US, LLC Bridgewater, NJ 08807 USA, Manufactured by: Bausch Health Companies, Inc. Laval Quebec H7L 448, Canada, NDC 0187-0006-25.

Share this recall: Facebook X / Twitter WhatsApp Email

Hazard / Issue

CGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining refrigerated.

Issued by

FDA

Distribution: Nationwide (United States)
Lot/Code Info: Lot: 7001796, Exp 05/31/2025

✅ What Should You Do?

  1. 1Stop taking this medication and contact your doctor or pharmacist immediately.
  2. 2Do NOT flush medications down the drain — use an FDA-approved drug take-back program.
  3. 3Check the lot number on your bottle or packaging against the recalled lots listed above.
  4. 4Report adverse events to FDA MedWatch or call 1-800-FDA-1088.
View official government recall